Cargando…

TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience

BACKGROUND: Hepatocellular carcinoma (HCC) with symptomatic portal hypertension (SPH) has poor prognosis. A transjugular intrahepatic portosystemic shunt (TIPS) relieves SPH, but its application in HCC remains unclear. We evaluated TIPS efficacy in patients with HCC and SPH. METHODS: Pre- and post-T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Huzheng, Qiu, Zhenkang, Xiang, Zhanwang, Feng, Kai, Huang, Mingsheng, Gao, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858571/ https://www.ncbi.nlm.nih.gov/pubmed/35183265 http://dx.doi.org/10.1186/s40644-022-00451-9

Ejemplares similares

TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension
por: Qiu, Zhenkang, et al.
Publicado: (2022)

Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites
por: Yan, Huzheng, et al.
Publicado: (2020)

Whole-course management of interventional treatment in liver cancer patients with portal hypertension
por: Qiu, Zhenkang, et al.
Publicado: (2019)

Clinical efficacy and prognostic factors of CT-guided (125)I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes
por: Yan, Huzheng, et al.
Publicado: (2020)

TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)
por: Xiang, Zhanwang, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched Study
por: Zhao, Chenghao, et al.
Publicado: (2023)

Single-Centre Retrospective Study Using Propensity Score Matching Comparing Left Versus Right Internal Jugular Vein Access for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation
por: Qiu, Zhenkang, et al.
Publicado: (2022)

Child-Na Score: A Predictive Model for Survival in Cirrhotic Patients with Symptomatic Portal Hypertension Treated with TIPS
por: Chen, Hui, et al.
Publicado: (2013)

Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts
por: Zhu, Wenliang, et al.
Publicado: (2022)

Role of circulating angiogenin levels in portal hypertension and TIPS
por: Queck, Alexander, et al.
Publicado: (2021)

CT-guided (125)I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
por: Yan, Huzheng, et al.
Publicado: (2016)

(125)I seed brachytherapy versus external beam radiation therapy for the palliation of painful bone metastases of lung cancer after one cycle of chemotherapy progression
por: Xiang, Zhanwang, et al.
Publicado: (2018)

Macroscopic Portal Vein Thrombosis in HCC Patients
por: Akkiz, Hikmet, et al.
Publicado: (2018)

CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017)

Portal Hypertension in Childhood Bilateral Wilms' Tumor Survivor: An Excellent Indication for TIPS
por: Nakib, Ghassan, et al.
Publicado: (2013)

Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial
por: Wang, Lei, et al.
Publicado: (2016)

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein
por: Li, Weixiao, et al.
Publicado: (2023)

Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience
por: Chen, Yun, et al.
Publicado: (2019)

O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis
por: Liu, Rui, et al.
Publicado: (2021)

Resection vs. ablation for lesions characterized as resectable-ablative within the colorectal liver oligometastases criteria: a propensity score matching from retrospective study
por: Luo, Ma, et al.
Publicado: (2020)

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
por: Balducci, Daniele, et al.
Publicado: (2023)

Hepatic sarcoidosis with symptomatic portal hypertension: A report of 12 cases with review of the literature
por: Fauter, Maxime, et al.
Publicado: (2022)

Palliative Liver Radiotherapy (RT) for Symptomatic Hepatocellular Carcinoma (HCC)
por: Yeung, Cynthia S. Y., et al.
Publicado: (2020)

Wall shear stress in portal vein of cirrhotic patients with portal hypertension
por: Wei, Wei, et al.
Publicado: (2017)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
por: Chen, Junwei, et al.
Publicado: (2023)

Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
por: Trebicka, Jonel, et al.
Publicado: (2013)

Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
por: Fichtl, Anna, et al.
Publicado: (2023)

Portal Hypertension
por: Sun, Mingyu, et al.
Publicado: (2018)

Portale Hypertension
por: Bauer, J., et al.
Publicado: (2011)

The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS
por: Jansen, Christian, et al.
Publicado: (2014)

TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis–A case series and review of the literature
por: Nordmann, Tamara, et al.
Publicado: (2021)

Can a laparoscopic surgery be an alternative to transjugular intrahepatic portosystemic shunts (TIPS) for the treatment of portal hypertensive bleeding?
por: Huang, Bin, et al.
Publicado: (2023)

The effects and safety of anticoagulation or antiplatelet therapy following TIPS in cirrhotic patients with portal hypertension: A meta-analysis
por: Xu, Xiaotong, et al.
Publicado: (2023)

Symptomatic Presentation of Intrahepatic Portal Vein Aneurysm
por: Philips, Cyriac Abby, et al.
Publicado: (2014)

Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus
por: Yang, Biao, et al.
Publicado: (2018)

TIPS performed in a patient with complete portal vein thrombosis
por: Sharma, Ashwani Kumar, et al.
Publicado: (2017)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation
por: Buechter, Matthias, et al.
Publicado: (2017)

Refractory portal hypertension complications successfully managed by parallel transjugular intrahepatic portosystemic shunt (TIPS): a case report
por: Weeratunga, Senali, et al.
Publicado: (2022)

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
por: Fan, Wenzhe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv1gkmarr87c1mlepb0av1t4pu